All In Biotech

Drug Trial Radar · NCT04846673

Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy

Efficacy and Safety of Pregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy: a Randomized, Parallel, Open-label, Multicenter, Phase IV Clinical Trial (OPTIMUM Trial)

Last checked: Nov 20, 2026Latest source record: Apr 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 151 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

151

Actual

Start

May 14, 2021

Primary completion

Nov 30, 2022

Study completion Nov 30, 2022

Sponsor

Lead sponsor
Yuhan CorporationIndustry
Sponsor type
Industry
First posted
Apr 15, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a randomized, parallel, open-label, multicenter, phase IV clinical trial to assess the efficacy and safety of pregabalin and alpha-lipoic acid combination compared with each monotherapy in patients with diabetic peripheral neuropathy for 12 weeks.

Conditions

  • Diabetic Peripheral Neuropathy

Interventions

  • Pregabalin 150mg + Alpha-lipoic acid 480mgDrug

    Pregabalin qd + alpha-lipoic acid qd

  • Pregabalin 150mgDrug

    pregabalin qd

  • Alpha-Lipoic Acid 480mgDrug

    alpha-lipoic acid qd

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. visual analogue scale (VAS)Time frame: 12 weeks

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Pusan National University Hospital

    Busan, South Korea

  • Chosun University Hospital, School of Medicine, Chosun University

    Gwangju, South Korea

  • Dongtan Sacred Heart Hospital, Hallym University College of Medicine

    Gyeonggi-do, South Korea

  • Seoul National University Bundang Hospital

    Gyeonggi-do, South Korea

  • The Catholic University of Korea, Incheon ST. Mary's Hospital

    Incheon, South Korea

  • Jeju National University College of Medicine

    Jeju City, South Korea

  • Jeonbuk National University Hospital

    Jeollabuk-do, South Korea

  • Asan Medical Center, University of Ulsan College of Medicine

    Seoul, South Korea

  • Inje University Sanggye Paik Hospital

    Seoul, South Korea

  • Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine

    Seoul, South Korea

  • Korea University Guro Hospital

    Seoul, South Korea

  • Seoul St.Mary's Hospital, The Catholic University of Korea

    Seoul, South Korea

  • Yeouido St. Mary's Hospital, The Catholic University of Korea

    Seoul, South Korea

  • Ulsan University Hospital, College of Medicine University of Ulsan

    Ulsan, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.